Tag: Cancer: Leukemia
Long-Term Remissions of CLL in First Personalized Cell Tx Trial
T cells reprogrammed to contain chimeric antigen receptor targeting CD19 protein on B cells
Addition of Glitazone to Chemo May Help Treat CML
Combining glitazones with standard treatment improved survival in small study
Older Cancer Patients Heavily Use Health Care Services
Regardless of chemo intensity, palliative care, hospice rarely used with acute myeloid leukemia
Genomic Approach Could Aid Risk Stratification in Adults With AML
Persistent leukemia-linked mutations in remission samples tied to increased relapse, worse survival
Medicare Will Cover Expensive New Leukemia Medication
Amgen's Blincyto costs about $178,000 for a standard course of treatment
Tyrosine Kinase Inhibitors Seem Safe in CML With CKD
In these patients, no further decline in GFR, regardless of TKI used
New Rx for Myeloid Malignancies Moves to Phase II Clinical Trials
Phase I trial involving 47 patients identified maximum tolerated dose of 400 mg once daily
Breastfeeding Tied to Lower Odds of Childhood Leukemia
One more potential benefit for breastfed babies, research suggests
ASCO: Rx Strategies Promising for CLL, Non-Hodgkin’s Lymphoma
Ibrutinib, obinutuzumab slow progression of CLL, non-Hodgkin's lymphoma
Increased Risk of Cancer Seen for Offspring of Older Fathers
Higher risk for blood and immune system cancers
